Bazar Gregory Matthew 4
Research Summary
AI-generated summary
SANUWAVE (SNVW) Director Gregory Bazar Receives 5,524-Share Award
What Happened
Gregory Matthew Bazar, a director of SANUWAVE Health, Inc. (SNVW), was granted derivative securities covering 5,524 shares on June 30, 2026. The Form 4 reports an acquisition price of $0.00 for the award; a footnote states the options were fully vested at the grant date. This filing records an award/acquisition (not a sale).
Key Details
- Transaction date: 2026-06-30; Form 4 filed: 2026-07-02.
- Transaction type: Grant / award of derivative securities (Form code A).
- Shares/units involved: 5,524 (reported acquisition price $0.00).
- Footnote: Options were fully vested at the grant date.
- Shares owned following the transaction: Not specified in the filing.
- No 10b5-1 plan, tax withholding, or cashless sale noted in this filing.
Context
The filing indicates these are derivative securities (options) granted and immediately vested. This is not an exercise or sale — it documents an award that gives the insider rights tied to 5,524 underlying shares. Awards can reflect compensation or retention arrangements; they do not by themselves indicate a sale of stock or immediate cash proceeds. If the options are exercised or underlying shares are later sold, subsequent filings would disclose those transactions.